| genes and pseudogenes, 1 trypanosomes evade their mammalian host's adaptive immune responses by antigenic variation. Thus there is no vaccine for sleeping sickness and chemotherapy relies on few available drugs, although more are entering the treatment pipeline. 2 Suramin is the oldest drug but remains used for the treatment of the first stage of T. b. rhodesiense infection. Despite the use of suramin for a hundred years, its mode of action against African trypanosomes is not completely understood. Suramin inhibits a number of different enzymes including many in the glycolytic pathway. 3 As a negatively charged molecule, suramin cannot cross membranes by diffusion and was proposed to be taken up through receptor-mediated endocytosis. 4, 5 More recent RNAi target sequencing studies showed that knock-down of a number of endosomal and lysosomal genes leads to up to about 11-fold suramin resistance, 6 substantiating an uptake route through endocytosis.
Invariant surface glycoprotein 75 (ISG75) was proposed to act as the suramin receptor, since its knock-down led to a decrease in suramin sensitivity. 6 Suramin shows a high plasma protein binding with approximately 70% bound to albumin, 15% to low-density lipoprotein (LDL) and 15% free. 5 Based on findings that trypanosomes took up >20-fold more suramin in the presence of LDL than in the presence of plasma, whereas the binding and uptake of LDL were up to 70% reduced in the presence of high micromolar concentrations of suramin, 5 suramin was proposed to be taken up in complex with LDL. However, procyclic trypanosomes overexpressing the trypanosome ortholog of Rab4 showed a 50% decrease in suramin binding and almost no suramin uptake when compared with parental cells, whereas the uptake of LDL was unchanged. 7 The expression of a constitutively activated version of Rab5 led to increased LDL uptake without affecting suramin uptake, indicating that uptake of LDL and suramin are likely independent. 7 While resistance to suramin is widespread in the animal pathogen Trypanosoma evansi with 50% inhibitory concentrations (IC 50 ) of up to 40 µg/mL, 8, 9 there have not been any reports of suramin resistance in T. brucei spp. from the field. Nevertheless, resistance can be selected for under in vitro and in vivo conditions in the laboratory. 10 We recently described a variant surface glycoprotein, VSG Sur , which is linked to suramin resistance. 11 VSG Sur was identified by forward genetics.
We had exposed T. b. rhodesiense STIB900 clones to high suramin concentrations (80-fold the IC 50 ), and within only one week they became resistant. Transcriptome sequencing showed that all the resistant lines had switched to express VSG Sur . This phenomenon was reproducible in multiple independent experiments. The VSG Sur expressing parasites showed an increase in IC 50 of almost 100-fold for suramin, and cross resistance to trypan blue, a trypanocidal dye related to suramin. We quantified the amount of intracellular trypan blue and observed a reduced uptake by VSG Sur expressing parasites. 11 In this study, we investigate the effects of enforced VSG Sur expression in a suramin-sensitive T. b. brucei line, aiming to uncover the molecular mechanisms underlying the link between VSG Sur expression and suramin resistance.
| MATERIALS AND METHODS
Chemicals were purchased from Merck KGaA, Darmstadt, Germany, if not otherwise stated. 
| T. brucei strains and cell culture

| ISG75 turnover
For each cell line and each timepoint, 40 mL cell cultures were prepared the day before the experiment. The cell density was adjusted for each sample to reach 1.2 × 10 cells/mL. The next day, at the respective time points, cycloheximide (C7698 Sigma, now Merck) was added to the cultures to a concentration of 100 µg/mL. At timepoint zero, the cell densities were measured and the same number of cells was taken from each replicate. Cells were centrifuged for 10 minutes, 1000 g at room temperature. The supernatant was removed and the cell pellet resuspended in 1 mL PBS supplemented with protease inhibitor (cOmplete™, Mini, EDTA-free Protease Inhibitor Cocktail, Roche: 1 tab in 20ml) and centrifuged for 10 minutes, 1000 g at room temperature. The cells were washed one more time with PBS containing protease inhibitor, supernatant was removed and 10 µL of 3 × Laemmli buffer added. Cells were further diluted with Laemmli buffer to reach a density of 5 × 10 6 cells/ 10 µl. Cells were sonicated and incubated at 70°C for 10 minutes. Samples were centrifuged at full speed in a microcentrifuge for 2 minutes and subsequently 10 µL of sample was loaded on a NuPAGE 4%-12% Bis-Tris Protein Gel (Fisher Scientific -UK Ltd) and run for 1 hour at 200 V in NuPAGE™ MOPS SDS Running Buffer (Fisher Scientific -UK Ltd). Separated proteins were transferred to a polyvinylidene difluoride (PVDF) membrane (Immobilon-P; Millipore) in a TE22 wet transfer tank (GE healthcare) in SDS-Page running buffer supplemented with 20% methanol. The membrane was blocked with blocking buffer consisting of Tris-buffered saline with 0.01% Tween-20 (TBST) and 5% milk powder. Subsequently the membrane was incubated for 1 hour in blocking buffer containing the primary antibody. For ISG75 a 1:2,500 diluted polyclonal rabbit antibody was used and for EF1α a monoclonal mouse antibody (clone CBP-KK1; Millipore) | was used in a 1:20 000 dilution. Membranes were washed with TBST three times for 5 minutes and incubated for one hour with a secondary goat anti-rabbit peroxidase-conjugated IgG (A0545, Sigma, now Merck) at a 1:20 000 dilution. Membranes were washed once with TBS and twice with PBS before the addition of 1 mL Amersham ECL Western Blotting Detection Reagent (GE Healthcare Life Sciences). After two minutes of incubation, chemiluminescence was detected with a G:box imager (Syngene). Signals were quantified using ImageJ (Fiji) software. 16 
| ISG75 knock-down
A previously described pRPa plasmid for RNAi-mediated knockdown of ISG75 6 was amplified in DH5α cells and digested with XhoI. A total of 6 µg purified digested plasmid was used to transfect 4 × 10 7 VSG 221 , respectively, VSG Sur expressing 2T1 cells. Transfection was carried out as described above and positive transfectants were selected with 10 µg/mL Hygromycin (Invivogen). Pseudoclones were picked after five days and RNAi-knockdown was induced by the addition of 1 µg/mL Tetracycline. To quantify the level of ISG75 knock-down, 72 hours after induction, RNA of induced and non-induced clones was isolated and qPCR was performed as described above 11 (Wiedemar et al, 2018 ).
11
Primers used for qPCR were ISG75qPCR_F (gcttgggttgcttgtgttct) and ISG75qPCR_R (tcgtatttttgcttttagcattagc).
| Suramin wash-out assay
Serial drug dilutions were prepared on a 96-well v-shaped plate with the following media: HMI-9 with 15% inactivated horse serum, HMI-9 without serum, HMI-9 without serum but complemented with 10 µg/mL LDL and HMI-9 without serum but complemented with 0.5% bovine serum albumin (BSA, A7030). Parasites were washed twice with pre-warmed IMDM, eluted in the respective media and added to the assay plates to a final volume of 100 µL/well and a concentration of 1 × 10 5 cells/mL for the HMI-9 medium with 15% inactivated horse serum. Since the cells in the media without serum were not dividing during the incubation time, higher inocula were used and parasites were added to a concentration of 2 × 10 5 cells/mL. Plates were incubated for 4 hours at 37°C, 5% CO 2 and subsequently centrifuged at 1000 g for 3 minutes. 50 µL of the supernatant was removed and 150 µL pre-warmed IMDM was added to all the wells. Cells were washed three more times, each time 150 µL supernatant was removed and 150 µL IMDM or, in case of the last wash, 150 µL HMI-9 with 15% i-horse was added. After the last centrifugation 150 µL supernatant was removed and 50 µL HMI-9 with 15% i-horse was added to elute the parasites. A new flatbottom plate was prepared with 50 µL HMI-9 with 15%
i-horse and 50 μL of the eluted parasites were transferred to the new plate. The flat-bottom plate was incubated for another 64 hours before resazurin was added to a final concentration of 11.4 µg/mL. After another 4-5 hours of incubation at 37°C, 5% CO 2 , fluorescence of viable cells was measured with a SpectraMax (Molecular Devices) and SoftMax Pro 5.4.5 Software. Dose-response curves were fitted with a nonlinear regression model (variable slope; four parameters, lowest value set to zero) and IC50 values were calculated with GraphPad Prism 6.00.
| Uptake and binding of transferrin and low-density lipoprotein
To quantify the uptake of transferrin and LDL, cells in the logarithmic growth phase were washed once with serum-free medium supplemented with 1% BSA and resuspended in serum-free medium supplemented with 1% BSA at a concentration of 2 × 10 6 cells/mL. 392 µL (for the transferrin uptake experiment) and 95 µL (for the LDL uptake experiment) of resuspended parasites were transferred to Eppendorf tubes. Cells were pre-incubated for 15 minutes at 37°C to internalize surface bound transferrin and LDL. At the respective timepoints fluorescently labeled transferrin (Alexa Fluor™ 488 Conjugate, T13342, Fisher Scientific, Illkirch Cedex, France) was added to a concentration of 50 µg/mL or fluorescently labeled LDL (Bodipy FL, I34359, Fisher Scientific, Illkirch Cedex, France) to a concentration of 10 µg/mL. At time point zero, cells were quenched by putting them on ice and by the addition of 1 mL ice-cold PBS. Cells were centrifuged for 5 minutes at 1000 g at 4°C and washed once with ice cold PBS. Cells were fixed and fluorescence quantified as described above.
To quantify the impact of suramin on the uptake of transferrin and LDL, cells were washed once with IMDM and eluted in IMDM without BSA to a concentration of 2 × 10 6 cells/mL. The experiment was performed without BSA, since otherwise the majority of suramin would bind to BSA. Cells were pre-incubated for 15 minutes (transferrin) or for one hour (LDL) at 37°C. Suramin was added to concentrations between 0 and 1000 µmol/L and subsequently transferrin or LDL were added to concentrations of 5 or 10 µg/mL, respectively. Cells were incubated for 10 minutes (transferrin) or for 20 minutes (LDL) at 37°C, quenched, washed, and fixed as described above. For the quantification of transferrin and LDL binding to the cell surface, cells were washed with IMDM and eluted in IMDM to a concentration of 1 × 10 7 cells/mL. Cells were pre-incubated for 15 minutes (transferrin) or for one hour (LDL) at 37°C and subsequently chilled on ice for 15 minutes. Either suramin or cold PBS was added and subsequently transferrin or LDL were added to a concentration of 800 or 100 µg/mL, respectively. Cells were incubated for 10 minutes on ice, subsequently washed twice with ice-cold PBS and fixed as described above.
| Concanavalin A uptake and binding
Trypanosomes in the logarithmic growth phase were centrifuged at 1000 g for 5 minutes, the cell pellet was eluted in IMDM with 1% bovine serum albumin (BSA) to a concentration of 2 × 10 6 cells/mL. 498 μL of eluted parasites were put in 1.5 ml Eppendorf tubes and pre-incubated at 37°C for 15 minutes. At the respective time points FITC conjugated Concanavalin A (C7642 Sigma, now Merck) was added to a concentration of 5 µg/mL. After incubation at 37°C cells were quenched on ice by the addition of ice-cold PBS. Subsequently cells were centrifuged for 5 minutes at 1000 g at 4°C and washed once with PBS. Cells were eluted in 250 µL PBS and fixed by the addition of 250 µL 10% formalin. For the quantification of surface bound ConA, cells were centrifuged and eluted in IMDM with 1% BSA to a concentration of 2 × 10 6 cells/mL. These were pre-incubated on ice for 15 minutes and subsequently the ConA was added to concentrations of 0, 5, 20, and 50 µg/mL. After incubation on ice for 10 minutes, ice-cold PBS was added, the cells centrifuged at 4°C (5 minutes, 1000 g) and subsequently washed one more time with ice-cold PBS, eluted in 250 µL PBS, and fixed by the addition of 250 µL 10% formalin. Fluorescent intensities of the cells were measured as described above but using the FL1 filter. Fluorescence values were defined as the geometrical mean fluorescence of >9000 events. Figure 1B) . Two of the VSG Sur expressing transfectants (2T1_sur1 and 2T1_sur4) were chosen for further analysis. Proliferation was essentially indistinguishable from the parent cell line when cultivated in standard medium without blasticidine ( Figure  1C ). The 50% inhibitory concentration (IC 50 ) for suramin increased from 12 nmol/L in the VSG 221 expressing parent to 700 nmol/L in the two VSG Sur expressing transfectants (P = 0.0036, One-Way ANOVA; Figure 1D ). Figure 2 ). This is consistent with the small increase in the IC 50 towards this compound.
| RESULTS
| Expression of
| VSG
Sur -mediated suramin resistance is not linked to ISG75
Since some suramin resistance can be caused by ISG75 depletion, 6 we investigated a possible effect of VSG Sur on ISG75 turnover. Therefore, cells were incubated with cycloheximide to block protein synthesis, and the steady-state ISG75 levels were determined after 0, 2, 4, and 6 hours by Western blotting. The ISG75 half-life was around 3 hours in both the VSG 221 expressing and the VSG Sur expressing trypanosomes ( Figure   3A ). We further investigated the effect of ISG75 depletion in VSG Sur -expressors (2T1_sur1) and parental cells (2T1_wt) by introduction of a pRPA-based, tetracycline-inducible RNAi knock-down construct. Induction of RNAi for 72 hours led to a 75%-85% reduction in ISG75 mRNA levels in 5 (2T1_wt_c1 and c3; 2T1_sur1_c1 to c3) of 6 clones as determined by qPCR ( Figure 3B ). Growth was slightly faster under knock-down of ISG75 with an average population doubling time of 6.9 hours in the presence of tetracycline compared to 7.2 hours without tetracycline (P-value = .003, paired t-test including all clones, Figure 3C ). Suramin sensitivity decreased in all the tested clones upon down-regulation of ISG75 ( Figure 3D ). The presence of ISG75-dependent suramin uptake also in the VSG Figure  3D ). This is in agreement with the above hypothesis, that a pathway distinct from ISG75 is affected and hence, ISG75 confers a larger proportion of suramin uptake in the VSG Sur expressing trypanosomes.
| Effects of serum proteins on suramin susceptibility
Having excluded defects toward ISG75 turnover as a reason for the decreased suramin sensitivity of VSG Sur expressing cells, we tested for the involvement of serum proteins in VSG Sur -mediated suramin resistance. This had to be performed with wash-out assays since the trypanosomes cannot be cultivated without serum proteins over long periods. -expressors were incubated for 4 hours with suramin in HMI-9 medium without serum proteins, in HMI-9 supplemented with albumin, with LDL or with serum, respectively, washed, and incubated in standard growth medium (without suramin) for 3 days. As expected, the IC 50 in these assays ( Figure 4 ) were higher than in the standard 72 hours assay, since suramin was only present for the first 4 hours. Nevertheless, cells incubated in medium without any serum proteins were highly sensitive to suramin: they showed a decrease in IC 50 of 98% for VSG 221 and of 95% for VSG Sur -expressing cells when compared with the IC 50 of cells incubated in medium with serum. This demonstrates that free suramin is taken up by trypanosomes. The addition of bovine serum albumin (BSA) counteracted suramin toxicity, indicating that suramin is sequestered by binding to albumin, which is in agreement with previous findings. 5 The same effect can also explain why the trypanosomes were less suramin sensitive in the presence of serum than without serum. The addition of LDL further increased suramin susceptibility of serum-free cultures (50% decrease in IC 50 ; Figure 4 Figure 5B ). To differentiate whether the reduced LDL uptake is mediated through a reduced binding or endocytosis, we looked at the binding of LDL to the cell surface. LDL binding at 4°C was around 30% reduced in VSG Sur compared to VSG 221 expressing cells (overall Pvalue = .0003, paired t-test). Thus, the highly reduced LDL uptake cannot be explained by a reduction in the binding alone and a reduced endocytosis seems to play a major role. No effect on binding was observed in the presence of suramin ( Figure 5C ).
| The effect of VSG
Sur and suramin on transferrin uptake
We investigated uptake of transferrin as an additional substrate that is imported by receptor-mediated endocytosis. 20, 21 Again, trypanosomes were incubated for different periods with fluorescently labeled transferrin at 37°C and analyzed by FACS. In VSG 221 expressing 2T1 cells transferrin was quickly internalized, reaching a plateau of more than four times background fluorescence after ten minutes ( Figure 6A ). In contrast, VSG Sur expressing 2T1 cells incubated with labeled transferrin only showed a slight increase in fluorescence F I G U R E 4 50% inhibitory concentrations in the presence of different serum proteins. Parasites were incubated either in standard growth medium with 15% inactivated horse serum (HMI-9), in HMImedium without any serum (no serum), in HMI-medium without serum supplemented with albumin (BSA), or in HMI-medium without serum supplemented with LDL (LDL). Values that differed significantly (P < .05, Tukey's multiple comparison test on logarithmic data) are labeled with different letters (a-g) (independent biological replicates: n = 3 for "HMI-9" and "BSA"; n = 4 for "no serum," and "LDL"; each biological replicate consisted of two technical replicates) to 1.5 times background level ( Figure 6A ), which corresponds to an 80% lower fluorescence than observed in parental cells. Since transferrin uptake had been described to be reduced in the presence of suramin in HeLa cells, 22 we investigated the effect of suramin on transferrin uptake in T. brucei. Cells were incubated with fluorescently labeled transferrin in different concentrations of suramin for 10 minutes (the incubation time was kept short to limit the toxic effects of suramin). At concentrations below 300 µmol/L, suramin had no effect on transferrin uptake; only at very high suramin concentrations, reduced amounts of intracellular transferrin were measured in VSG 221 expressing cells ( Figure 6B, P values to suramin of around 1.2 µmol/L, which was almost 100-fold above the IC 50 of the parental cells but still below the suramin plasma levels of 70 µmol/L in treated patients. 29 Thus the expression of VSG Sur is unlikely to cause suramin treatment failure in patients. Nevertheless, it is intriguing how a particular VSG can be linked to drug susceptibility. Here we show that transgenic expression of VSG Sur is sufficient to cause suramin resistance in T. b. brucei, which is otherwise highly sensitive to the drug. Based on the reduced uptake of trypan blue by the cells that express VSG Sur , our working hypothesis is that suramin resistance is mediated by a reduced drug uptake. Trypanosomes take up suramin through receptor-mediated endocytosis. 4, 5 Endocytosis in trypanosomes takes place at the flagellar pocket and the most abundantly endocytosed protein is VSG itself. VSGs are endocytosed into Rab5a endosomes 30 at a very high rate. 23 Subsequently the VSG is recycled back to the trypanosome surface by exocytosis via Rab11 exocytic carriers. Concanavalin A, a lectin which binds to VSG, can be used as a marker to track VSG internalization. 32 We did not observe distinct alterations of ConA endocytosis in VSG Sur expressing trypanosomes, neither by flow cytometry nor by fluorescence microscopy (not shown) and conclude that if there is an effect on VSG internalization at all, it is only marginal. Transferrin and low-density lipoprotein (LDL) are important nutrients for African trypanosomes. 33, 34 Transferrin binds to the transferrin receptor, which is a heterodimer of ESAG6 and ESAG7, and is subsequently endocytosed in Rab5a endosomes similar to the VSGs. 30 Once the ligand is removed, transferrin receptors are recycled to the cell membrane. Similar to VSG, this happens at a very high rate with a turnover of only 11 minutes. 35 LDL is imported via receptor-mediated endocytosis as well. The LDL receptor is supposedly located at the flagellar pocket and on the flagellar membrane, 36 but it has not been identified. As determined by flow cytometry, the VSG Sur -expressors showed highly reduced intracellular levels of fluorescently labeled transferrin and fluorescently labeled LDL after incubation at 37°C. This suggests that VSG Sur expression impairs endocytosis of the LDL receptor and the transferrin receptor. However, the expression of VSG Sur did not alter sensitivity to human serum, indicating that endocytosis of the TbHpHb receptor is not affected. The HpHb receptor is a glycosylphosphatidylinositol (GPI) anchored, glycosylated surface protein located at the flagellar pocket. 28 Taken together, VSG Sur -expressors showed a normal growth and no enlarged flagellar pockets, thus we assume that VSG Sur has no effect on bulk endocytosis. Receptor-mediated endocytosis is affected by VSG Sur , but only specific pathways. While endocytosis of transferrin is highly reduced, endocytosis of the VSG may be moderately reduced, and endocytosis of the HpHb receptor unaffected by VSG Sur expression. Additionally, and most importantly for suramin susceptibility, endocytosis of the elusive LDL receptor is highly reduced. Suramin inhibited uptake of LDL by VSG 221 expressing cells, in agreement with published results, 5 but not in VSG Sur expressing cells. Short-term suramin wash-out experiments in serum-free medium indicated that suramin uptake is lowest in the presence of albumin and intermediate in the presence of serum, which confirms the literature. 5 We further
| F I G U R E 7
show for the first time that suramin is also taken up in the absence of serum. Suramin remains an enigmatic molecule with polypharmacology and multiple potential uses. The effects of suramin on vesicular trafficking are likely to be complex, since suramin can interfere with vesicular transport and is imported via receptor-mediated endocytosis itself. 4, 5, 7 Our findings support a model of two independent pathways for endocytosis of suramin by trypanosomes: via the invariant surface glycoprotein ISG75 that directly binds suramin, and via the LDL receptor, a protein of unknown nature that binds suramin complexed to LDL. While the former is still active in cells expressing VSG Sur , the latter is strongly impaired, causing suramin resistance in T. brucei.
